Biosimilars: What Can Retina Learn from Oncology?

Related

• 

  Best Corrected Visual Acuity (BCVA) and Central Macular Thickness (MAT) Outcomes After Fluocinolone Acetonide Intravitreal Implant Injection

  Dana M. Deupree, MD

  Annual Meeting Talks

  2018

• 

  Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial

  Nancy M. Holekamp, MD, FASRS

  Updates from the Field

  2016

• 

  Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials

  Jennifer I. Lim, MD, FARVO, FASRS

  Updates from the Field

  2022